Carlos del Rio - (Chair)
Carlos del Rio, M.D., is the Hubert Professor and Chair of the Department of Global Health, a professor of epidemiology at the Rollins School of Public Health, and a professor of medicine in the Division of Infectious Diseases at Emory University School of Medicine. He is also principal investigator and co-Director of the Emory Center for AIDS Research. Dr. del Rio is a native of Mexico, where he attended medical school at Universidad La Salle, graduating in 1983. He did his internal medicine and infectious diseases residencies at Emory University. In 1989 he returned to Mexico, where he was Executive Director of the National AIDS Council of Mexico (CONASIDA, the Federal agency of the Mexican Government responsible for AIDS Policy throughout Mexico), from 1992 through 1996. In November 1996, he returned to Emory where he has been involved in patient care, teaching and research. Dr. del Rio was Chief of the Emory Medical Service at Grady Memorial Hospital from 2001–2009 and since 2017 is the Interim Executive Associate Dean for Emory at Grady. Dr. del Rio’s research focuses on the early diagnosis, access to care, engagement in care, compliance with antiretrovirals, and the prevention of HIV infection. He has worked for over a decade with hard-to-reach populations, including persons who use drugs, to improve outcomes of those infected with HIV and to prevent infection with those at risk. He is also interested in the translation of research findings into practice and policy. Dr. del Rio is conducting a National Institute on Drug Abuse-funded study entitled “Improving physician opioid prescribing for HIV-infected patients with chronic pain”. He is co-PI of the National Institutes of Health-funded Emory–Centers for Disease Control and Prevention (CDC) HIV Clinical Trials Unit, Clinical Site Leader for the Adult AIDS Clinical Trials Group and the site PI for the HIV Prevention Trials Network of the National Institute of Allergy and Infectious Diseases. His international work includes collaborations in the countries of Georgia, Ethiopia, Kenya, Thailand, Vietnam, and Mexico. He has also worked on emerging infections, such as pandemic influenza, and was a member of the World Health Organization Influenza A (H1N1) Clinical Advisory Group and of the CDC Influenza A (H1N1) Task Force during the 2009 pandemic.
Julie A. Baldwin
Julie A. Baldwin, Ph.D., is director of a new center on health equity research, and a professor in the Department of Health Sciences in the College of Health and Human Services at Northern Arizona University (NAU). Prior to that, she was on the faculty at the University of South Florida (USF) College of Public Health in the Department of Community and Family Health. Before joining USF, she served as a tenured faculty member at Northern Arizona University, with a joint appointment in the Mel and Enid Zuckerman Arizona College of Public Health. She has worked for over 28 years with tribal communities in northern Arizona to design culturally relevant health promotion programs for youth and their families.
Dr. Baldwin’s research over the years has focused on both infectious and chronic disease prevention targeting children, adolescents, and families. Cross-cutting themes which have characterized her work include: utilizing community-based participatory research approaches, working with underserved and/or marginalized populations, and addressing health disparities by developing and implementing culturally competent public health interventions. She has been PI or Co-PI of several federally funded projects from such agencies as CDC, NIMH, NIAAA, NIDA, NIMHD, the Robert Wood Johnson Foundation and HRSA/AMERSA-SAMHSA/CSAT. For over 28 years, Dr. Baldwin has had a consistent program of applied research addressing HIV/AIDS and substance abuse prevention in youth, with a special emphasis on American Indian adolescents and their families. She continues to contribute significantly to this field of research today, as the Co-Director of a NIDA Research Education grant, the “Institute for Translational Research in Adolescent Behavioral Health” and Co-Director of another NIDA grant entitled, the “Intertribal Talking Circle for the Prevention of Substance Abuse in Native Youth.”
She earned her doctorate in Behavioral Sciences and Health Education in 1991 from the Johns Hopkins University School of Hygiene and Public Health. As an enrolled member of the Cherokee Nation of Oklahoma, she has made a life-long commitment to serving diverse communities and to advocating for health promotion programs for children, adolescents and families.
Edwin C. Chapman, M.D., is the Chief Medical Officer of Medical Home Development Group, a multi-specialty physician led, physician owned Medical Service Organization headquartered in Washington, DC. Dr. Chapman has delivered high quality care in Washington, DC for 40 years, specializing in Internal Medicine and Addiction Medicine. He currently collaborates with the Howard University Urban Health Initiative as an Adjunct Assistant Professor, Department of Behavioral Health and Psychiatry investigating the complex mix of addiction, undertreated mental illness, infectious diseases (AIDS & hepatitis C), criminal behavior, and chronic diseases. Using an innovative “virtual office telemedicine design,” that initiative brought together the Departments of Behavioral Health and Psychiatry, Family and Community Medicine, Internal Medicine, and Pediatrics in a successful collaboration with the DC Department of Community Health addressing the needs of opioid addicted index patients and their entire families.
Hannah Cooper, Sc.D., is the Rollins Chair in Substance Use Disorders. Dr. Cooper is a professor and vice chair in the Department of Behavioral Sciences and Health Education at Rollins, co-director of the Prevention Science Core at the Emory Center for AIDS Research and director of Rollins’ Socio-Contextual Determinants of Health certificate program. Dr. Cooper’s research primarily focuses on social determinants of HIV-related outcomes, particularly among people who use drugs. She currently leads five NIH-funded studies on these topics—including the CARE2HOPE project, which studies substance misuse and related harms among people who inject opioids in rural Kentucky. Her work has been cited in the National HIV/AIDS Strategy for the United States and has been published in numerous preeminent journals including the American Journal of Public Health, the Journal of Urban Health and Social Science & Medicine. Dr. Cooper received her bachelor’s from Yale, followed by her Sc.D. in health and social behavior from Harvard, then completed her postdoctoral fellowship in drug use and HIV at the National Development and Research Institutes. Since joining Rollins in 2008, Dr. Cooper has gained the respect of colleagues and collaborators across the University. She was recognized for her outstanding leadership qualities with the Emory Williams Teaching Award in 2015.
David H. Gustafson
Dave Gustafson, Ph.D., directs the University of Wisconsin-Madison’s Center for Health Enhancement Systems Studies. His research interests focus on developing systems engineering tools to support sustainable individual and organizational improvement in addiction, cancer and aging. NIATx grew to a network of more 3,000 addiction treatment agencies and has conducted nationwide experiments to test the effectiveness of quality improvement models to enhance access to and retention in addiction treatment. His other implementation research interests focus on developing systems engineering tools to encourage individual and organizational change. His individual change research develops and tests computer systems (CHESS) to help people deal with serious illness The addiction program–ACHESS–has been used by over 6,000 patients. Randomized trials found that ACHESS reduced risky drinking, improved retention in treatment and abstinence. Other versions of CHESS have also improved outcomes in areas such as breast, lung and colon cancer as well as HIV and asthma. Dr. Gustafson and his colleagues have produced models to predict and explain implementation, sustainability and diffusion of innovations, as well as models to measure quality of care and understand customer needs. He is an author on over 300 reviewed publications including seven books. He is a member of the National Academy of Engineering, and Fellow of the Association for Health Services Research, the American Medical Informatics Association, the WK Kellogg Foundation and the Institute for Healthcare Improvement, which he co-founded and was board vice-chair. He co-chaired the federal Science Panel on Interactive Communications in Health, served on several NIH Study Sections and is a member of the National Advisory Council of the Substance Abuse and Mental Health Services Administation. He serves on two National Academies committees.